AbCellera Biologics Inc.
NASDAQAbCellera Biologics has delivered the post-earnings explosion that the crowded short setup was threatening — a 60% weekly surge that has reshuffled every layer of the trade. The catalyst was the August 10 earnings print. The stock jumped 40.8% the day after results landed, the sharpest single-day move in the recent history. That followed a 7.2% move on August 5, suggesting the…
Snapshot as of 16 Sept 2026
AbCellera Biologics has delivered the post-earnings explosion that the crowded short setup was threatening — a 60% weekly surge that has reshuffled every layer of the trade. The catalyst was the August 10 earnings…
AbCellera Biologics heads into its Monday earnings report with a setup that hasn't changed much since Friday's preview: short interest remains deeply dug in, the stock has just posted a sharp weekly rally, and analysts…
AbCellera Biologics reports Monday with an unusually charged setup: 15% short interest, a stock that just surged 21% in a week, and two analyst target raises filed the morning after the last quarterly print. Short…
AbCellera Biologics heads into the back half of June with a striking internal contradiction: short sellers have been piling in all week, yet options traders are as bullish as they've been in over a year. Short interest…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABCL — free to start on ORTEX.
Sign up for free →Open ABCL on ORTEX